Doug Kerr

Senior Director, Neurology Research & Development at Biogen MA, Inc.

Doug Kerr

Doug Kerr

Senior Director, Neurology Research & Development at Biogen MA, Inc.

Biography

Doug is CSO at Generation Bio. Previously, he ran Shire’s rare neuroscience franchise, including BD/portfolio management, transition into development and all clinical activity. Prior to that, Doug worked at Biogen as the global lead for a series of programs in Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA). He was the global lead for Biogen’s nusinersen (Spinraza), the first approved drug for SMA. Doug has over 120 publications in medical journals. He received his MD and PhD from Jefferson Medical College; his MBA from Northeastern; and his B.A. from Princeton. He completed his neurology residency at The Johns Hopkins University School of Medicine and subsequently served as an Associate Professor of Neurology.

Overview
RelSci Relationships

709

Number of Boards

3

Relationships
RelSci Relationships are individuals Doug Kerr likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at Cure SMA

Relationship likelihood: Strong

Director at Alliance for Regenerative Medicine

Relationship likelihood: Strong

Treasurer & Director at Alliance for Regenerative Medicine

Relationship likelihood: Strong

General Manager, Cell Therapy at GE Healthcare, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Q Therapeutics, Inc.

Relationship likelihood: Strong

Venture Partner at Atlas Venture, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Cure SMA

Relationship likelihood: Strong

Medical Director at Cure SMA

Relationship likelihood: Strong

Professor at The Ohio State University - College of Medicine

Relationship likelihood: Strong

Member, Scientific Advisory Board at Cure SMA

Relationship likelihood: Strong

Paths to Doug Kerr
Potential Connections via
Relationship Science
You
Doug Kerr
Senior Director, Neurology Research & Development at Biogen MA, Inc.
Career History
Senior Director, Neurology Research & Development
Current

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company's research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

Advisor
Current

Atlas Venture focuses on investments in early-stage companies operating in the fields of biotechnology. The firm partners with entrepreneurs to build companies around innovative science.

Other Affiliations

Doug Kerr is affiliated with Biogen MA, Inc., Atlas Venture, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Doug Kerr. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Doug Kerr's profile does not indicate a business or promotional relationship of any kind between RelSci and Doug Kerr.